Baidu
map

A&R:Notch-1在高安动脉炎患者MTOR过度活跃和血管炎症中的关键作用

2022-07-28 MedSci原创 MedSci原创

来自Takayasu动脉炎(TA)患者的CD4+ T细胞中Notch-1的表达升高,导致mTORC1过度活跃和促炎T细胞分化。靶向Notch-1是TA临床管理的一种有前途的治疗策略。

目的Takayasu动脉炎(TA)是一种主要影响主动脉和主要分支的慢性和进行性自身免疫性血管血管炎,特征是血管层存在进行性炎症。在来自苏州大学最近的研究中,研究团队确定了雷帕霉素机制靶标(mTOR)过度活跃在TA中促炎T细胞分化中的核心作用。本研究旨在探索支持T细胞内在mTOR过度活跃和 TA血管炎症的潜在机制,重点是Notch-1

方法根据Notch-1、活化的Notch-1HES-1水平确定Notch-1的表达和活性。研究人员通过测量细胞内磷酸化核糖体蛋白S6表达的方法来检测mTOR活性。通过检测Th1Th17谱系决定转录因子来分析促炎T 细胞的分化。使用γ-分泌酶抑制剂DAPT和使用短发夹RNA (shRNA)策略的基因敲低评估Notch-1的功能。使用人源化NSG小鼠嵌合体进行转化研究,使用来自TA患者的免疫细胞诱导了人类血管炎。

结果来自TA患者的CD4+ T细胞高表达Notch-1,并导致mTOR过度活跃和Th1 细胞和Th17细胞的自发分化不良。使用DAPTNotch-1 shRNA阻断Notch-1有效地消除了 mTOR 复合物1 (mTORC1)激活和促炎T细胞分化。机制上,Notch-1促进mTOR表达,与mTOR相互作用,并与mTOR的溶酶体定位相关。因此,DAPTCD4+ T细胞特异性基因敲除Notch-1的全身给药可以减轻人源化TA嵌合体的血管炎症。

结论来自TA患者的CD4+ T细胞中Notch-1的表达升高,导致mTORC1过度活跃和促炎T细胞分化。靶向Notch-1TA临床管理的一种有前途的治疗策略。

出处:Jiang W, Sun M, Wang Y, et al. Critical Role of Notch-1 in Mechanistic Target of Rapamycin Hyperactivity and Vascular Inflammation in Patients With Takayasu Arteritis. Arthritis Rheumatol. 2022 Jul;74(7):1235-1244. doi: 10.1002/art.42103. Epub 2022 Jun 2. PMID: 35212196.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2036824, encodeId=78342036824dc, content=<a href='/topic/show?id=6cd1129e190' target=_blank style='color:#2F92EE;'>#Notch-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12971, encryptionId=6cd1129e190, topicName=Notch-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Dec 15 03:42:35 CST 2022, time=2022-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683234, encodeId=3423168323465, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Wed Jan 11 11:42:35 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797073, encodeId=c0e71e9707317, content=<a href='/topic/show?id=045222331db' target=_blank style='color:#2F92EE;'>#中的关键作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22331, encryptionId=045222331db, topicName=中的关键作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu May 18 04:42:35 CST 2023, time=2023-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042847, encodeId=beb3204284ed0, content=<a href='/topic/show?id=ef3a94013ff' target=_blank style='color:#2F92EE;'>#过度活跃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94013, encryptionId=ef3a94013ff, topicName=过度活跃)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sun Apr 02 17:42:35 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263280, encodeId=b3bb126328075, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373806, encodeId=2c6b13e38067d, content=<a href='/topic/show?id=eb3b129e01d' target=_blank style='color:#2F92EE;'>#Notch#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12970, encryptionId=eb3b129e01d, topicName=Notch)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ece5364, createdName=karmond, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479178, encodeId=3b1b14e91784c, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487508, encodeId=6c12148e50860, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]
    2022-12-15 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2036824, encodeId=78342036824dc, content=<a href='/topic/show?id=6cd1129e190' target=_blank style='color:#2F92EE;'>#Notch-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12971, encryptionId=6cd1129e190, topicName=Notch-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Dec 15 03:42:35 CST 2022, time=2022-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683234, encodeId=3423168323465, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Wed Jan 11 11:42:35 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797073, encodeId=c0e71e9707317, content=<a href='/topic/show?id=045222331db' target=_blank style='color:#2F92EE;'>#中的关键作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22331, encryptionId=045222331db, topicName=中的关键作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu May 18 04:42:35 CST 2023, time=2023-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042847, encodeId=beb3204284ed0, content=<a href='/topic/show?id=ef3a94013ff' target=_blank style='color:#2F92EE;'>#过度活跃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94013, encryptionId=ef3a94013ff, topicName=过度活跃)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sun Apr 02 17:42:35 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263280, encodeId=b3bb126328075, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373806, encodeId=2c6b13e38067d, content=<a href='/topic/show?id=eb3b129e01d' target=_blank style='color:#2F92EE;'>#Notch#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12970, encryptionId=eb3b129e01d, topicName=Notch)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ece5364, createdName=karmond, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479178, encodeId=3b1b14e91784c, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487508, encodeId=6c12148e50860, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]
    2023-01-11 xsm927
  3. [GetPortalCommentsPageByObjectIdResponse(id=2036824, encodeId=78342036824dc, content=<a href='/topic/show?id=6cd1129e190' target=_blank style='color:#2F92EE;'>#Notch-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12971, encryptionId=6cd1129e190, topicName=Notch-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Dec 15 03:42:35 CST 2022, time=2022-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683234, encodeId=3423168323465, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Wed Jan 11 11:42:35 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797073, encodeId=c0e71e9707317, content=<a href='/topic/show?id=045222331db' target=_blank style='color:#2F92EE;'>#中的关键作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22331, encryptionId=045222331db, topicName=中的关键作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu May 18 04:42:35 CST 2023, time=2023-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042847, encodeId=beb3204284ed0, content=<a href='/topic/show?id=ef3a94013ff' target=_blank style='color:#2F92EE;'>#过度活跃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94013, encryptionId=ef3a94013ff, topicName=过度活跃)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sun Apr 02 17:42:35 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263280, encodeId=b3bb126328075, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373806, encodeId=2c6b13e38067d, content=<a href='/topic/show?id=eb3b129e01d' target=_blank style='color:#2F92EE;'>#Notch#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12970, encryptionId=eb3b129e01d, topicName=Notch)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ece5364, createdName=karmond, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479178, encodeId=3b1b14e91784c, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487508, encodeId=6c12148e50860, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2036824, encodeId=78342036824dc, content=<a href='/topic/show?id=6cd1129e190' target=_blank style='color:#2F92EE;'>#Notch-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12971, encryptionId=6cd1129e190, topicName=Notch-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Dec 15 03:42:35 CST 2022, time=2022-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683234, encodeId=3423168323465, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Wed Jan 11 11:42:35 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797073, encodeId=c0e71e9707317, content=<a href='/topic/show?id=045222331db' target=_blank style='color:#2F92EE;'>#中的关键作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22331, encryptionId=045222331db, topicName=中的关键作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu May 18 04:42:35 CST 2023, time=2023-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042847, encodeId=beb3204284ed0, content=<a href='/topic/show?id=ef3a94013ff' target=_blank style='color:#2F92EE;'>#过度活跃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94013, encryptionId=ef3a94013ff, topicName=过度活跃)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sun Apr 02 17:42:35 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263280, encodeId=b3bb126328075, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373806, encodeId=2c6b13e38067d, content=<a href='/topic/show?id=eb3b129e01d' target=_blank style='color:#2F92EE;'>#Notch#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12970, encryptionId=eb3b129e01d, topicName=Notch)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ece5364, createdName=karmond, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479178, encodeId=3b1b14e91784c, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487508, encodeId=6c12148e50860, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2036824, encodeId=78342036824dc, content=<a href='/topic/show?id=6cd1129e190' target=_blank style='color:#2F92EE;'>#Notch-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12971, encryptionId=6cd1129e190, topicName=Notch-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Dec 15 03:42:35 CST 2022, time=2022-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683234, encodeId=3423168323465, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Wed Jan 11 11:42:35 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797073, encodeId=c0e71e9707317, content=<a href='/topic/show?id=045222331db' target=_blank style='color:#2F92EE;'>#中的关键作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22331, encryptionId=045222331db, topicName=中的关键作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu May 18 04:42:35 CST 2023, time=2023-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042847, encodeId=beb3204284ed0, content=<a href='/topic/show?id=ef3a94013ff' target=_blank style='color:#2F92EE;'>#过度活跃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94013, encryptionId=ef3a94013ff, topicName=过度活跃)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sun Apr 02 17:42:35 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263280, encodeId=b3bb126328075, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373806, encodeId=2c6b13e38067d, content=<a href='/topic/show?id=eb3b129e01d' target=_blank style='color:#2F92EE;'>#Notch#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12970, encryptionId=eb3b129e01d, topicName=Notch)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ece5364, createdName=karmond, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479178, encodeId=3b1b14e91784c, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487508, encodeId=6c12148e50860, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2036824, encodeId=78342036824dc, content=<a href='/topic/show?id=6cd1129e190' target=_blank style='color:#2F92EE;'>#Notch-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12971, encryptionId=6cd1129e190, topicName=Notch-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Dec 15 03:42:35 CST 2022, time=2022-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683234, encodeId=3423168323465, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Wed Jan 11 11:42:35 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797073, encodeId=c0e71e9707317, content=<a href='/topic/show?id=045222331db' target=_blank style='color:#2F92EE;'>#中的关键作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22331, encryptionId=045222331db, topicName=中的关键作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu May 18 04:42:35 CST 2023, time=2023-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042847, encodeId=beb3204284ed0, content=<a href='/topic/show?id=ef3a94013ff' target=_blank style='color:#2F92EE;'>#过度活跃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94013, encryptionId=ef3a94013ff, topicName=过度活跃)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sun Apr 02 17:42:35 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263280, encodeId=b3bb126328075, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373806, encodeId=2c6b13e38067d, content=<a href='/topic/show?id=eb3b129e01d' target=_blank style='color:#2F92EE;'>#Notch#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12970, encryptionId=eb3b129e01d, topicName=Notch)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ece5364, createdName=karmond, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479178, encodeId=3b1b14e91784c, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487508, encodeId=6c12148e50860, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]
    2022-07-29 karmond
  7. [GetPortalCommentsPageByObjectIdResponse(id=2036824, encodeId=78342036824dc, content=<a href='/topic/show?id=6cd1129e190' target=_blank style='color:#2F92EE;'>#Notch-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12971, encryptionId=6cd1129e190, topicName=Notch-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Dec 15 03:42:35 CST 2022, time=2022-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683234, encodeId=3423168323465, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Wed Jan 11 11:42:35 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797073, encodeId=c0e71e9707317, content=<a href='/topic/show?id=045222331db' target=_blank style='color:#2F92EE;'>#中的关键作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22331, encryptionId=045222331db, topicName=中的关键作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu May 18 04:42:35 CST 2023, time=2023-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042847, encodeId=beb3204284ed0, content=<a href='/topic/show?id=ef3a94013ff' target=_blank style='color:#2F92EE;'>#过度活跃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94013, encryptionId=ef3a94013ff, topicName=过度活跃)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sun Apr 02 17:42:35 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263280, encodeId=b3bb126328075, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373806, encodeId=2c6b13e38067d, content=<a href='/topic/show?id=eb3b129e01d' target=_blank style='color:#2F92EE;'>#Notch#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12970, encryptionId=eb3b129e01d, topicName=Notch)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ece5364, createdName=karmond, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479178, encodeId=3b1b14e91784c, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487508, encodeId=6c12148e50860, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=2036824, encodeId=78342036824dc, content=<a href='/topic/show?id=6cd1129e190' target=_blank style='color:#2F92EE;'>#Notch-1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12971, encryptionId=6cd1129e190, topicName=Notch-1)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Thu Dec 15 03:42:35 CST 2022, time=2022-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683234, encodeId=3423168323465, content=<a href='/topic/show?id=60f03325e28' target=_blank style='color:#2F92EE;'>#动脉炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33257, encryptionId=60f03325e28, topicName=动脉炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d22a27947071, createdName=xsm927, createdTime=Wed Jan 11 11:42:35 CST 2023, time=2023-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797073, encodeId=c0e71e9707317, content=<a href='/topic/show?id=045222331db' target=_blank style='color:#2F92EE;'>#中的关键作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22331, encryptionId=045222331db, topicName=中的关键作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu May 18 04:42:35 CST 2023, time=2023-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042847, encodeId=beb3204284ed0, content=<a href='/topic/show?id=ef3a94013ff' target=_blank style='color:#2F92EE;'>#过度活跃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94013, encryptionId=ef3a94013ff, topicName=过度活跃)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e30378, createdName=caobinglei8079, createdTime=Sun Apr 02 17:42:35 CST 2023, time=2023-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263280, encodeId=b3bb126328075, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373806, encodeId=2c6b13e38067d, content=<a href='/topic/show?id=eb3b129e01d' target=_blank style='color:#2F92EE;'>#Notch#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12970, encryptionId=eb3b129e01d, topicName=Notch)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ece5364, createdName=karmond, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479178, encodeId=3b1b14e91784c, content=<a href='/topic/show?id=5d67896914c' target=_blank style='color:#2F92EE;'>#血管炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89691, encryptionId=5d67896914c, topicName=血管炎症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92a47497019, createdName=ms6832696159214430, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487508, encodeId=6c12148e50860, content=<a href='/topic/show?id=ba951352387' target=_blank style='color:#2F92EE;'>#OTC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13523, encryptionId=ba951352387, topicName=OTC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b36f8313624, createdName=ymljack, createdTime=Fri Jul 29 01:42:35 CST 2022, time=2022-07-29, status=1, ipAttribution=)]
    2022-07-29 ymljack

相关资讯

CLIN CANCER RES:靶向TFE3/IRS-1/PI3K/mTOR轴治疗易位肾细胞癌

易位肾细胞癌(tRCC)是一种罕见的肾癌亚型,与TFE3,TFEB或MITF基因融合有关,对RCC的标准治疗无反应。因此,需要寻找新的治疗靶标。CLIN CANCER RES近期发表了一篇文章研究这一问题。

Blood:特发性多中心Castleman病的mTOR激活增强

在特发性多中心Castleman病(iMCD)中,mTOR通路被过度激活,并被作为候选新型治疗靶点。 mTOR在iMCD中的激活程度与mTOR驱动的自身免疫性淋巴组织增生综合征的相似。

Cell子刊:癌症治疗专用代餐?可阻止三阴乳腺癌进展和癌症干细胞逃逸!

Cell Metab:模拟禁食饮食可以阻止三阴乳腺癌和癌症干细胞逃逸

Nat Commun:全基因组CRISPR筛选揭示乳腺癌的易感性和mTOR/Hippo协同潜在靶向治疗策略

乳腺癌作为影响全球妇女的一大疾病,其发病率和死亡率逐年上升。

Blood:急性髓系白血病的新靶点——新型CDK9复合物!

中心点:CDK9与mTOR复合物胞内原件的不同部位结合,形成CDK9-mTOR样复合物(CTORC1和CTORC2)。CTORC1控制对白血病发生重要的基因的转录,而CTORC2调控mRNA的翻译。摘要:在急性髓系白血病(AML)中,mTOR信号的异常激活可导致存活优势,从而促进恶性表型。为了提高我们对mTOR信号激活因子的认识,鉴别新的治疗靶点,Elspeth M. Beauchamp等人通过蛋

Gastroenterology:mTORC1/2聚集在Arp2/3复合体上促进腺泡→导管化生→早期胰腺癌转化进展

致癌基因Kras通过以肌动蛋白为基础的形态发生过程-腺泡-导管化生(ADM)诱导胰腺腺泡细胞的肿瘤转化,并导致胰腺导管腺癌(PDAC)。mTOR复合物1(mTORC1)和2(mTORC2)分别含有Rp

Baidu
map
Baidu
map
Baidu
map